NewsSource: EClinCloud Official Website Archive

CMAC Recap | Charting Digital Clinical Research Practices with AI

2 min readEClinCloud Editorial Team
CMAC Recap | Charting Digital Practice in Clinical Research with AI (archived article cover)

From March 18 to 20, the 2025 CMAC Annual Conference was successfully held in Suzhou, where EClinCloud presented its AI-driven digital clinical research solutions.

2025 CMAC大会现场  

 

At this conference, EClinCloud Co-Founder & Chief Business Officer Su Quanyu was invited to deliver a keynote speech titled "Crossing Boundaries, Addressing Needs: Enabling Clinical Trials with eCOA," offering an accessible exploration of the regulatory requirements and application potential of AI + eCOA—regulations set the boundaries, while the application of AI drives innovation within the compliance framework to push those boundaries further.

2025 CMAC大会演讲与圆桌讨论  

 

 

01 Boundaries: eCOA Policy Direction

 

Overview of International Regulatory Developments

This presentation systematically analyzes a series of guidance documents on eCOA/ePRO from regulatory agencies such as the FDA, EMA, and NMPA, summarizing common requirements and regional regulatory differences. Regulatory authorities across countries explicitly support and encourage the use of eCOA systems in clinical trials, emphasizing the importance of efficient data collection and standardized management for improving clinical trial quality.

eCOA与ePRO相关监管文件时间线  

 

Validation of Academic Research Value

Based on multiple literature searches and systematic analyses, it summarizes that the clinical value of eCOA is primarily reflected in areas such as improving trial participant compliance and experience, enhancing data quality, standardizing patient management, and reducing costs while improving efficiency; it further explores the value eCOA can provide in clinical practice through decentralized remote visits, trial participant management, and more complete, accurate, timely, and compliant study data.

eCOA患者监测相关研究证据展示

02 Crossing Boundaries: AI Accelerates Intelligent Upgrades

 

The presentation also focused on the current application of AI technology in clinical trials, outlined the evaluation frameworks and review requirements for AI tools from agencies such as the FDA, EMA, and NMPA, and expressed anticipation for subsequent guidance documents.

人工智能相关监管文件时间线  

 

At the same time, drawing on EClinCloud's practice, opening perspectives were shared from three angles—patient experience and adherence management, data quality and compliance, and intelligent assisted decision support—to spark discussion and explore with on-site guests AI-enablement areas in eCOA systems.

This discussion cut through the confusion amid the wave of digitalization for attendees and illustrated the broad prospects for AI-enabled clinical trials.

一临云2025 CMAC展台与演讲活动回顾  

 

Looking ahead, EClinCloud will continue to explore the deep integration of AI technology and clinical research, empower industry development through digital innovation, and work alongside global partners to jointly advance the intelligent development of clinical research.

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.